Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026)
Acadia Pharmaceuticals (ACAD) posted quarterly Exchange Rate Effect of $25000.0 for Q1 2026, up 600.0% year-over-year from $3571.4 in Q1 2025, and up 257.14% quarter-over-quarter from $7000.0 in Q4 2025.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 600.0% year-over-year to $25000.0; the TTM figure through Mar 2026 stood at $56000.0 (up 153.85% YoY), while the FY2025 annual figure was $26000.0, up 127.66% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $25000.0, up from $7000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $25000.0 in Q1 2026, with the low at -$60000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is $2000.0 (2022), against an average of -$3666.7.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect tumbled 950.0% in 2024, then soared 700.0% in 2025.
- Acadia Pharmaceuticals' Exchange Rate Effect stood at -$8000.0 in 2022, then slumped by 50.0% to -$12000.0 in 2023, then plunged by 400.0% to -$60000.0 in 2024, then jumped by 111.67% to $7000.0 in 2025, then soared by 257.14% to $25000.0 in 2026.
- Business Quant data shows ACAD's Exchange Rate Effect at $25000.0 in Q1 2026, $7000.0 in Q4 2025, and $24000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Acadia Pharmaceuticals | 4.82 Bn | 3.86 Bn | 279.64 Mn | 27,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Mar 31, 2023 | -2,000.00 |
| Dec 31, 2022 | -8,000.00 |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | -2,000.00 |
| Mar 31, 2021 | 5,000.00 |